Variations in insulin secretion in carriers of the E23K variant in the KIR6.2 Subunit of the ATP-sensitive K+ channel in the β-cell

Diabetes

Volumn 51, Issue 10, 2002, Pages 3135-3138

  't Hart, Leen M ^a   Van Haeften, Timon W ^b   Dekker, Jacqueline M ^c   Bot, Martine ^a   Heine, Robert J ^c   Antonie Maassen, J ^a,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GENE PRODUCT; GLUCOSE; GLUTAMIC ACID; INSULIN; LYSINE; MEMBRANE PROTEIN; POTASSIUM CHANNEL; POTASSIUM ION; PROTEIN KIR6.2; PROTEIN SUBUNIT; SULFONYLUREA RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL LINE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0036788335     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.10.3135     Document Type: Article

References (24)

1. Aguilar-Bryan L, Clement JP, Gonzalez G, Kunjilwar K, Babenko A, Bryan J: Toward understanding the assembly and structure of K-ATP channels. Physiol Rev 78:227-245, 1998
2. + channel in insulin-secreting pancreatic beta-cells. J Molecular Endocrinol 22:113-123, 1999
3. 't Hart LM, Dekker JM, Van Haeften TW, Ruige JB, Stehouwer CD, Erkelens DW, Heine RJ, Maassen JA: Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus. Diabetologia 43:515-519, 2000
4. Reis AF, Velho G: Sulfonylurea receptor-1 (SUR1): genetic and metabolic evidences for a role in the susceptibility to type 2 diabetes mellitus. Diabete Metab 28:14-19, 2002
5. Sakura H, Wat N, Horton V, Millns H, Turner RC, Ashcroft FM: Sequence variations in the human KIR6.2 gene, a subunit of the beta-cell ATP-sensitive k-channel: no association with NIDDM in white Caucasian subjects or evidence of abnormal function when expressed in vitro. Diabetologia 39:1233-1236, 1996
6. Inoue H, Ferrer J, Warrenperry M, Zhang Y, Millns H, Turner RC, Elbein SC, Hampe CL, Suarez BK, Inagaki N, Seino S, Permutt MA: Sequence variants in the pancreatic islet β-cell inwardly rectifying K+ channel KIR6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes 46:502-507, 1997
7. Hansen L, Echwald SM, Hansen T, Urhammer SA, Clausen JO, Pedersen O: Amino acid polymorphisms in the ATP-regulatable inward rectifier KIR6.2 and their relationships to glucose- and tolbutamide-induced insulin secretion, the insulin sensitivity index, and NIDDM. Diabetes 46:508-512, 1997
8. Hani EH, Boutin P, Durand E, Inoue H, Permutt MA, Velho G, Froguel P: Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia 41:1511-1515, 1998
9. Gloyn AL, Hashim Y, Ashcroft SJ, Ashfield R, Wiltshire S, Turner RC: Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and KIR6.2 with type 2 diabetes mellitus (UKPDS 53). Diabet Med 18:206-212, 2001
10. Schwanstecher C, Meyer U, Schwanstecher M: K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic β-cell ATP-sensitive K(+) channels. Diabetes 51:875-879, 2002
11. Bergman RN, Phillips LS, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and B-cell glucose sensitivity from the response to intraveneous glucose. J Clin Invest 68:1456-1467, 1981
12. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte D Jr: Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42:1663-1672, 1993
13. 't Hart LM, De Knijff P, Dekker JM, Stolk RP, Nijpels G, Vanderdoes FEE, Ruige JB, Grobbee DE, Heine RJ, Maassen JA: Variants in the sulphonylurea receptor gene: association of the exon 16-3t variant with Type II diabetes mellitus in Dutch Caucasians. Diabetologia 42:617-620, 1999
14. Elbein SC, Sun J, Scroggin E, Teng K, Hasstedt SJ: Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1α genes. Diabetes Care 24:472-478, 2001
15. Bergman RN, Finegood DT, Kahn SE: The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 32 (Suppl. 3):35-45, 2002
16. Van Haeften TW, Zonderland ML, Dubbeldam S, Erkelens DW: Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects: assessments using hyperglycemic glucose clamps and oral glucose tolerance tests. Diabetes Care 21:278-282, 1998
17. Van Haeften TW, Pimenta W, Mitrakou A, Korytkowski M, Jenssen T, Yki-Jarvinen H, Gerich JE: Disturbances in β-cell function in impaired fasting glycemia. Diabetes 51 (Suppl. 1):S265-S270, 2002
18. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ: Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA 285:2109-2113, 2001
19. + channel mutation have normal glucose tolerance and insulin sensitivity and appropriate insulin secretion. Diabetes Care 25:101-106, 2002
20. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no 727)
21. Ruige JB, Dekker JM, Nijpels G, Poppsnijders C, Stehouwer CDA, Kostense PJ, Bouter LM, Heine RJ: Hyperproinsulinaemia in impaired glucose tolerance is associated with a delayed insulin response to glucose. Diabetologia 42:177-180, 1999
22. 't Hart LM, Nijpels G, Dekker JM, Maassen JA, Heine RJ, Van Haeften TW: Variations in insulin secretion in carriers of gene variants in IRS-1 and -2. Diabetes 51:884-887, 2002
23. Van Haeften TW, Boonstra E, Veneman TF, Gerich JE, van der Veen EA: Dose-response characteristics for glucose-stimulated insulin release in man and assessment of influence of glucose on arginine-stimulated insulin release. Metabolism 39:1292-1299, 1990
24. Mitrakou A, Vuorinen-Markkola H, Raptis G, Toft I, Mokan M, Strumph P, Pimenta W, Veneman T, Jenssen T, Bolli G, Korytkowski M, Yki-Jarvinen H, Gerich J: Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemic clamp. J Clin Endocrinol Metab 75:379-382, 1992